Biogen Inc (BIIB)

BIIB (NASDAQ:Drugs) EQUITY
$276.02
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | BIIB Avg Daily Volume: 1,796,300
Last Update: 01/23/17 - 4:00 PM EST
Volume: 0
YTD Performance: -2.67%
Open: $0.00
Previous Close: $276.02
52 Week Range: $223.02 - $333.65
Oustanding Shares: 217,574,479
Market Cap: 61,064,453,276
6-Month Chart
TheStreet Ratings Grade for BIIB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 11 9 8
Moderate Buy 1 1 1 1
Hold 4 4 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.53 1.53 1.78 1.83
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 19.07
Price Earnings Comparisons:
BIIB Sector Avg. S&P 500
19.07 15.90 30.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-5.03% 2.64% -12.36%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.80 0.90 0.25
Net Income 22.20 1.60 0.37
EPS 24.00 1.60 0.38
Earnings for BIIB:
EBITDA 4.28B
Revenue 9.42B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $4.97 $4.99 $20.18 $21.12
Number of Analysts 20 15 20 20
High Estimate $5.50 $5.66 $20.69 $23.31
Low Estimate $4.61 $4.59 $19.78 $19.17
Prior Year $4.50 $4.79 $17.01 $20.18
Growth Rate (Year over Year) 10.43% 4.18% 18.61% 4.69%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
A merger would be smart, profitable ... and attention-grabbing.
Potential acquirers include Gilead Sciences, Johnson & Johnson, Pfizer, Merck and Novartis.
Potential acquirers include Gilead Sciences, Johnson & Johnson, Pfizer, Merck and Novartis.
Drug giants with money to spend and a friendlier regulatory environment should spur deals.
With weak chart patterns and a quantitative downgrade, longs should protect their positions.
Six reasons why the Nasdaq 100 ETF seems ready to pull back.
Microsoft (MSFT) , which makes up about 8.6% of the index. Amazon (AMZN) , which has about a 6.4% weighting. Cisco (CSCO) , which accounts for about 2.7% on QQQ. I've previously written that I'm bearish on Cisco on an intermediate-term basis. Non-Tech QQQ Stocks Look Iffy, Too Some non-tech QQQ components could weigh down the ETF in 2017 as well. These include biotech and health care companies such as Amgen (AMGN) , Biogen (BIIB) , Celgene (CELG) , Express Scripts (ESRX) and others, which all could suffer if Trump tries to limit drug-price increases. Comcast (CMCSA) also represents a relatively large QQQ weighting (about 3%), but the cable giant could suffer from continued "cord cutting" by consumers. Tax Cuts Won't Help QQQ Stocks Trump's plan to lower the effective U.S. corporate tax rate won't materially benefit QQQ components. After all, large tech and health care firms in the Nasdaq 100 already g
Shoppers may want to wait until after the holidays for a bargain on BIIB.
The worst appears to be over for this sector; we could see big growth ahead.
Today high-growth tech and natural resources stocks are both going higher without sending much lower at all.

Columnist Conversations

We have some losers here not performing, we'll cut bait SOLD SLB FEB 87.5 CALL AT .45 SOLD MS FEB...
Altria is trading above its 2016 high today as its winning streak stretches to a sixth straight session. ...
Shares of Home Depot appear to be ending a seven week consolidation with a fresh breakout today.  The sto...
The first full week of the Trump Era starts on a cautious note in the market as all the major indices are down...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.